Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Gastric Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 97 articles: HTML format Text format

Single Articles

March 2012
1. DU C , Zhou Y, Cai H, Zhao G, et al
   Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: A comparative analysis of three subgroups.
   J Surg Oncol. 2012;105:323-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. SCORILAS A , Mavridis K
   Kallikrein-related peptidases (KLKs) as novel potential biomarkers in gastric cancer: An open yet challenging road lies ahead.
   J Surg Oncol. 2012;105:223-4.
   PubMed     Text format     Related articles   
   
   
   
   January 2012
3. LEE H , Lee YC, Shin S, Park JC, et al
   Participation and conflict in the decision-making process for endoscopic resection or surgical gastrectomy for early gastric cancer.
   J Surg Oncol. 2012 Jan 18. doi: 10.1002/jso.23049.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LI Y , Chen CQ, He YL, Cai SR, et al
   Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
   J Surg Oncol. 2012 Jan 9. doi: 10.1002/jso.23008.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LIN XD , Chen SQ, Qi YL, Zhu JW, et al
   Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma.
   J Surg Oncol. 2012 Jan 9. doi: 10.1002/jso.23037.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. WU Y , Yamada S, Izumi H, Li Z, et al
   Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer.
   J Surg Oncol. 2012 Jan 3. doi: 10.1002/jso.23030.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. LI P , Qian J, Yu G, Chen Y, et al
   Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
   J Surg Oncol. 2012;105:31-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. IMANO M , Imamoto H, Itoh T, Satou T, et al
   Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection.
   J Surg Oncol. 2012;105:43-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
9. TONG JH , Sun Z, Zhu Z, Wang ZN, et al
   Prognostic significance of lymph node station 7 for patients with gastric cancers underwent radical surgery.
   J Surg Oncol. 2011 Dec 27. doi: 10.1002/jso.23011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SHIMIZU H , Ichikawa D, Komatsu S, Okamoto K, et al
    The decision criterion of histological mixed type in "T1/T2" gastric carcinoma-comparison between TNM classification and Japanese classification of gastric cancer.
    J Surg Oncol. 2011 Dec 20. doi: 10.1002/jso.23010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. LI ZY , Koh CE, Bu ZD, Wu AW, et al
    Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer.
    J Surg Oncol. 2011 Dec 20. doi: 10.1002/jso.23009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. KIM HI , Kim H, Cho HW, Kim SY, et al
    The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
    J Surg Oncol. 2011;104:728-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
13. ZHU GL , Sun Z, Wang ZN, Xu YY, et al
    Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    J Surg Oncol. 2011 Nov 21. doi: 10.1002/jso.22149.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. CHEN YB , Hou JH, Feng XY, Chen S, et al
    Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas.
    J Surg Oncol. 2011 Nov 17. doi: 10.1002/jso.22151.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CHEN Y , Pan K, Li S, Xia J, et al
    Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer.
    J Surg Oncol. 2011 Nov 17. doi: 10.1002/jso.22150.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. OKUGAWA Y , Toiyama Y, Tanaka K, Matsusita K, et al
    Clinical significance of zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer.
    J Surg Oncol. 2011 Nov 17. doi: 10.1002/jso.22142.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. MUNENE G , Francis W, Garland SN, Pelletier G, et al
    The quality of life trajectory of resected gastric cancer.
    J Surg Oncol. 2011 Nov 17. doi: 10.1002/jso.22139.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. WOO Y , Hyung WJ, Obama K, Kim HI, et al
    Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
    J Surg Oncol. 2011 Oct 24. doi: 10.1002/jso.22129.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. OYAMA K , Fushida S, Kinoshita J, Makino I, et al
    Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    J Surg Oncol. 2011 Oct 17. doi: 10.1002/jso.22125.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. EOM BW , Lee JH, Choi IJ, Kook MC, et al
    Pretreatment risk factors for multiple gastric cancer and missed lesions.
    J Surg Oncol. 2011 Oct 17. doi: 10.1002/jso.22124.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. ZORCOLO L , Rosman AS, Pisano M, Marcon F, et al
    A meta-analysis of prospective randomized trials comparing minimally invasive and open distal gastrectomy for cancer.
    J Surg Oncol. 2011;104:544-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. DING J , Liao GQ, Liu HL, Liu S, et al
    Meta-analysis of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer.
    J Surg Oncol. 2011 Sep 22. doi: 10.1002/jso.22098.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. OH CA , Bae JM, Oh SJ, Choi MG, et al
    Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.
    J Surg Oncol. 2011 Sep 6. doi: 10.1002/jso.22091.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. EOM BW , Lee JH, Lee JS, Kim MJ, et al
    Survival analysis of gastric cancer patients with tumor thrombus in the portal vein.
    J Surg Oncol. 2011 Sep 6. doi: 10.1002/jso.22083.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SHIM JH , Lee HH, Yoo HM, Jeon HM, et al
    Intragastric approach for submucosal tumors located near the Z-line: a hybrid laparoscopic and endoscopic technique.
    J Surg Oncol. 2011;104:312-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
26. WANG LB , Teng RY, Jiang ZN, Hu WX, et al
    Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
    J Surg Oncol. 2011 Aug 31. doi: 10.1002/jso.22085.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. DREZNIK A , Purim O, Idelevich E, Kundel Y, et al
    Gastric cancer: Biology and clinical manifestations in Israel.
    J Surg Oncol. 2011 Aug 31. doi: 10.1002/jso.22078.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. FUJIWARA Y , Takiguchi S, Nakajima K, Miyata H, et al
    Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
    J Surg Oncol. 2011 Aug 31. doi: 10.1002/jso.22057.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HSIEH FJ , Wang YC, Hsu JT, Liu KH, et al
    Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger.
    J Surg Oncol. 2011 Aug 24. doi: 10.1002/jso.22084.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
30. YOO HM , Lee HH, Shim JH, Jeon HM, et al
    Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer.
    J Surg Oncol. 2011 Jul 25. doi: 10.1002/jso.22045.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BABA K , Ishigami S, Arigami T, Uenosono Y, et al
    Mesothelin expression correlates with prolonged patient survival in gastric cancer.
    J Surg Oncol. 2011 Jul 20. doi: 10.1002/jso.22024.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KIM DH , Oh CA, Oh SJ, Choi MG, et al
    Validation of seventh edition AJCC gastric cancer staging modifications.
    J Surg Oncol. 2011 Jul 14. doi: 10.1002/jso.22026.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. NAGATA T , Ichikawa D, Komatsu S, Inoue K, et al
    Prognostic impact of microscopic positive margin in gastric cancer patients.
    J Surg Oncol. 2011 Jul 8. doi: 10.1002/jso.22022.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LEE HH , Hur H, Jung H, Jeon HM, et al
    Analysis of 151 consecutive gastric submucosal tumors according to tumor location.
    J Surg Oncol. 2011;104:72-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
35. GILL RS , Al-Adra DP, Nagendran J, Campbell S, et al
    Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity.
    J Surg Oncol. 2011 Jun 28. doi: 10.1002/jso.22017.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LU X , Liu J, Li H, Li W, et al
    Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-beta1.
    J Surg Oncol. 2011 Jun 21. doi: 10.1002/jso.22005.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. RYU KW , Eom BW, Nam BH, Lee JH, et al
    Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies.
    J Surg Oncol. 2011 Jun 21. doi: 10.1002/jso.21995.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. KIM DH , Oh SJ, Oh CA, Choi MG, et al
    The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy.
    J Surg Oncol. 2011 Jun 21. doi: 10.1002/jso.21919.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PAK KH , Yun M, Cheong JH, Hyung WJ, et al
    Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.
    J Surg Oncol. 2011 Jun 13. doi: 10.1002/jso.21997.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. JIANG CG , Wang ZN, Sun Z, Liu FN, et al
    Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study.
    J Surg Oncol. 2011;103:700-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
41. JUNG MR , Park YK, Jeong O, Seon JW, et al
    Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.
    J Surg Oncol. 2011 May 25. doi: 10.1002/jso.21986.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. OH HH , Lee SE, Choi IS, Choi WJ, et al
    The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
    J Surg Oncol. 2011 May 25. doi: 10.1002/jso.21985.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ZHAO ZS , Li L, Wang HJ, Wang YY, et al
    Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer.
    J Surg Oncol. 2011 May 25. doi: 10.1002/jso.21984.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. SAITO H , Kihara K, Kuroda H, Matsunaga T, et al
    Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis.
    J Surg Oncol. 2011 May 25. doi: 10.1002/jso.21983.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. YOO HM , Lee HH, Shim JH, Jeon HM, et al
    Long-term outcomes and survival after laparoscopy-assisted distal gastrectomy for gastric cancer: Three-year survival analysis of a single-center experience in Korea.
    J Surg Oncol. 2011 May 25. doi: 10.1002/jso.21982.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. WEN YG , Wang Q, Zhou CZ, Yan DW, et al
    Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    J Surg Oncol. 2011 May 25. doi: 10.1002/jso.21981.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
47. VALENTI V , Hernandez-Lizoain JL, Beorlegui MC, Diaz-Gozalez JA, et al
    Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy.
    J Surg Oncol. 2011 Apr 20. doi: 10.1002/jso.21947.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. TOMIMARU Y , Miyashiro I, Kishi K, Motoori M, et al
    Is routine measurement of amylase concentration in drainage fluid necessary after total gastrectomy for gastric cancer?
    J Surg Oncol. 2011 Apr 14. doi: 10.1002/jso.21938.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
49. YE YW , Dong RZ, Zhou Y, Du CY, et al
    Prognostic analysis of familial gastric cancer in Chinese population.
    J Surg Oncol. 2011 Mar 11. doi: 10.1002/jso.21896.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. EROGLU A
    Serum levels of vascular endothelial growth factor in gastric cancer patients.
    J Surg Oncol. 2011 Mar 4. doi: 10.1002/jso.21900.
    PubMed     Text format     Related articles   
    
    
    
    
51. MAHAR AL , Qureshi AP, Ottensmeyer CA, Pollett A, et al
    A descriptive analysis of gastric cancer specimen processing techniques.
    J Surg Oncol. 2011;103:248-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. ZHANG M , Zhu GY, Gao HY, Zhao SP, et al
    Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
    J Surg Oncol. 2011;103:243-7.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
53. PUIG-COSTA M , Oliveras-Ferraros C, Flaquer S, Llopis-Puigmarti F, et al
    Antibody microarray-based technology to rapidly define matrix metalloproteinase (MMP) signatures in patients undergoing resection for primary gastric carcinoma.
    J Surg Oncol. 2011 Feb 9. doi: 10.1002/jso.21887.
    PubMed     Text format     Related articles   
    
    
    
    
54. YASUDA H , Toiyama Y, Ohi M, Mohri Y, et al
    Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
    J Surg Oncol. 2011 Feb 9. doi: 10.1002/jso.21877.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BEN AYED-GUERFALI D , Benhaj K, Khabir A, Abid M, et al
    Hypermethylation of tumor-related genes in tunisian patients with gastric carcinoma: Clinical and biological significance.
    J Surg Oncol. 2011 Feb 9. doi: 10.1002/jso.21875.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ZHANG D , Wang Z, Luo Y, Xu Y, et al
    Analysis of DNA copy number aberrations by multiple ligation-dependent probe amplification on 50 intestinal type gastric cancers.
    J Surg Oncol. 2011;103:124-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. WANG YY , Ye ZY, Li L, Zhao ZS, et al
    ADAM 10 is associated with gastric cancer progression and prognosis of patients.
    J Surg Oncol. 2011;103:116-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. CAO W , Yang W, Li H, Lou G, et al
    Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer.
    J Surg Oncol. 2011;103:110-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
59. CAO W , Yang W, Li H, Lou G, et al
    Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ZHANG D , Wang Z, Luo Y, Xu Y, et al
    Analysis of DNA copy number aberrations by multiple ligation-dependent probe amplification on 50 intestinal type gastric cancers.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. ANG SD
    Gastric cancer surgery: Can east meet west?
    J Surg Oncol. 2010;102:736.
    PubMed     Text format     Related articles   
    
    
    
    
62. JIANG CG , Wang ZN, Sun Z, Liu FN, et al
    Clinicopathologic characteristics and prognosis of gastric cancer invading the subserosa.
    J Surg Oncol. 2010;102:737-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
63. WANG YY , Ye ZY, Li L, Zhao ZS, et al
    ADAM 10 is associated with gastric cancer progression and prognosis of patients.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. DE BREE E , Charalampakis V, Melissas J, Tsiftsis DD, et al
    The extent of lymph node dissection for gastric cancer: A critical appraisal.
    J Surg Oncol. 2010;102:552-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. REIM D
    Invited commentary on: "The extent of lymph node dissection for gastric cancer: A critical appraisal by eelco de bee, Vasilis charalampakis, John Melissas, Dimitris D. Tsiftsis".
    J Surg Oncol. 2010;102:551.
    PubMed     Text format     Related articles   
    
    
    
    
66. RAUSEI S , Frattini F, Dionigi G, Boni L, et al
    Unusual rectal stenosis.
    J Surg Oncol. 2010;102:713.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
67. CAO L , Hu X, Zhang Y, Huang G, et al
    Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. PARK CH , Rha SY, Jeung HC, Kang SH, et al
    Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray.
    J Surg Oncol. 2010;102:454-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. LI C , Yan M, Chen J, Xiang M, et al
    Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination.
    J Surg Oncol. 2010;102:361-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. NISSAN A , Garofalo A, Esquivel J
    Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: why haven't we reached the promised land?
    J Surg Oncol. 2010;102:359-60.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
71. ISHIGAMI S , Ueno S, Arigami T, Arima H, et al
    Clinical implication of CD166 expression in gastric cancer.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. UBUKATA H , Motohashi G, Tabuchi T, Nagata H, et al
    Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. ARIGAMI T , Uenosono Y, Hirata M, Hagihara T, et al
    Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. LIU X , Cheng Y, Sheng W, Lu H, et al
    Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: Analysis of 104 cases.
    J Surg Oncol. 2010;102:249-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LEE HE , Kim MA, Lee BL, Kim WH, et al
    Low Ki-67 proliferation index is an indicator of poor prognosis in gastric cancer.
    J Surg Oncol. 2010;102:201-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. ARCIERO CA
    Ki-67 proliferation index and gastric cancer: Answers or more questions.
    J Surg Oncol. 2010;102:199-200.
    PubMed     Text format     Related articles   
    
    
    
    
77. HUR H , Lee HH, Jung H, Song KY, et al
    Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: Indications for staging laparoscopy.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
78. MAKINO H , Kunisaki C, Izumisawa Y, Tokuhisa M, et al
    Effect of obesity on laparoscopy-assisted distal gastrectomy compared with open distal gastrectomy for gastric cancer.
    J Surg Oncol. 2010;102:141-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. VALLBOHMER D , Holscher AH, Schneider PM, Schmidt M, et al
    [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.
    J Surg Oncol. 2010;102:135-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. AUGUST DA , Gannon C
    Guest editorial: Neoadjuvant therapy, predictors of response, and patient outcomes.
    J Surg Oncol. 2010;102:107-8.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
81. TSIRLIS TD , Kostakis A, Papastratis G, Masselou K, et al
    Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. LIM JS , Lee SK, Hyung WJ, Choi JY, et al
    CT colonography for postoperative surveillance after curative gastrectomy in patients with gastric cancer.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. AN JY , Heo GU, Cheong JH, Hyung WJ, et al
    Assessment of open versus laparoscopy-assisted gastrectomy in lymph node-positive early gastric cancer: a retrospective cohort analysis.
    J Surg Oncol. 2010;102:77-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. NOZOE T , Iguchi T, Egashira A, Adachi E, et al
    Pathological prognostic score as a simple criterion to predict outcome in gastric carcinoma.
    J Surg Oncol. 2010;102:73-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. YUE Z , Song Y, Wang Z, Luo Y, et al
    Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    J Surg Oncol. 2010;102:68-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. ZHANG M , Zhu GY, Zhang HF, Gao HY, et al
    Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
    J Surg Oncol. 2010;102:64-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. COBURN NG , Lourenco LG, Rossi SE, Gunraj N, et al
    Management of gastric cancer in Ontario.
    J Surg Oncol. 2010;102:54-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
88. WANG X , Cao W, Mo M, Wang W, et al
    VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. REIM D , Huser N, Humberg D, Novotny A, et al
    Preoperative clinically inapparent leucopenia in patients undergoing neoadjuvant chemotherapy for locally advanced gastric cancer is not a risk factor for surgical or general postoperative complications.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. SHI Y , Zhou Y
    The role of surgery in the treatment of gastric cancer.
    J Surg Oncol. 2010;101:687-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. SAITO H , Kuroda H, Matsunaga T, Fukuda K, et al
    Prognostic indicators in node-negative advanced gastric cancer patients.
    J Surg Oncol. 2010;101:622-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
92. YANG XJ , Li Y, Yonemura Y
    Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
    J Surg Oncol. 2010;101:457-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
93. MEZHIR JJ , Tang LH, Coit DG
    Neoadjuvant therapy of locally advanced gastric cancer.
    J Surg Oncol. 2010;101:305-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. JEONG SH , Ahn HS, Yoo MW, Cho JJ, et al
    Increased morbidity rates in patients with heart disease or chronic liver disease following radical gastric surgery.
    J Surg Oncol. 2010;101:200-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
95. SHIN SH , Bae JM, Jung H, Choi MG, et al
    Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
96. PARK JH , Hyung WJ, Choi SH, Noh SH, et al
    Should direct mesocolon invasion be included in T4 for the staging of gastric cancer?
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. MAHAR AL , Qureshi AP, Ottensmeyer CA, Chetty R, et al
    Improving the quality of processing gastric cancer specimens: The pathologist's perspective.
    J Surg Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: